Charles River Laboratories International (CRL) Long-Term Deferred Tax (2016 - 2025)
Charles River Laboratories International (CRL) has 16 years of Long-Term Deferred Tax data on record, last reported at $67.3 million in Q4 2025.
- For Q4 2025, Long-Term Deferred Tax rose 59.64% year-over-year to $67.3 million; the TTM value through Dec 2025 reached $67.3 million, up 59.64%, while the annual FY2025 figure was $67.3 million, 59.64% up from the prior year.
- Long-Term Deferred Tax reached $67.3 million in Q4 2025 per CRL's latest filing, up from $36.9 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $67.3 million in Q4 2025 and bottomed at $31.9 million in Q2 2021.
- Average Long-Term Deferred Tax over 5 years is $41.4 million, with a median of $40.3 million recorded in 2023.
- Peak YoY movement for Long-Term Deferred Tax: dropped 9.98% in 2024, then skyrocketed 59.64% in 2025.
- A 5-year view of Long-Term Deferred Tax shows it stood at $40.2 million in 2021, then increased by 2.58% to $41.3 million in 2022, then decreased by 2.38% to $40.3 million in 2023, then increased by 4.72% to $42.2 million in 2024, then surged by 59.64% to $67.3 million in 2025.
- Per Business Quant database, its latest 3 readings for Long-Term Deferred Tax were $67.3 million in Q4 2025, $36.9 million in Q3 2025, and $46.9 million in Q2 2025.